Clinical Trials in Chicago

Showing 8641-8660 of 15,574 trials

Vaccine Therapy for Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL)

NCT01976520

This Phase I trial studies the safety and efficacy of vaccine therapy in treating patients with previously untreated chronic lymphocytic leukemia. Liposome-based vaccines containing an extract of a person's cancer cells and the immunostimulant interleukin-2 may help the body to build an effective immune response to kill cancer cells.

Chronic Lymphocytic Leukemia (CLL)

XEME Biopharma Inc.30 participantsStarted Oct 2013

Chicago, Illinois, United States

COMPLETEDPhase 22.2 miles

A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL)

NCT03292406

To assess the efficacy, safety and pharmacokinetics in participants treated with CD11301 gel vs. placebo for early stage CTCL (IA, IB, or IIA).

Cutaneous T Cell Lymphoma

Galderma R&D86 participantsStarted Dec 2017

Orange, California, United States • Palo Alto, California, United States • Farmington, Connecticut, United States +18 more locations

Vaccine Therapy for Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL)

A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL)

Find Trials by Condition in Chicago

Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer

Abdomen - Fat Reduction and Muscle Toning

Degenerative Mitral Regurgitation in Intermediate Risk Patients

Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab

ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian Cancer

Essure (Model ESS310) Placement Rate Study

Rheos System for the Treatment of HFpEF Heart Failure

ARQ 197 for Participants With Relapsed or Refractory Germ Cell Tumors

Afrezza Safety and Pharmacokinetics Study in Pediatric Patients

A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD)

Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 When Given Together With Chemotherapy and the Effectiveness of This Combination Treatment in Shrinking a Specific Type of Lung Tumors (Small Cell Lung Cancer)

Clinical Endpoint Bioequivalence Study of Test and Reference Inhalation Products in Patients With COPD With Device Robustness

Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes

A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.

Ultra-Low Tidal Volume Mechanical Ventilation in ARDS Through ECMO

A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin Before

Peer Led Asthma Self Management for Adolescents: PLASMA

Wide Frequency Band Test of Hearing in Veterans